Evgen Pharma (LSE:EVG)

UK company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - EVG

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - EVG

  • Market Cap£21.030m
  • SymbolLSE:EVG
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINGB00BSVYN304

Company Profile

Evgen Pharma PLC is a UK-based clinical-stage drug development company. The company is focused on the development of sulforaphane-based compounds. Its core technology is Sulforadex, which synthesis and stabilizes the naturally occurring compound sulforaphane. Geographically, it operates only in the United Kingdom. It is engaged in the treatment of breast cancer and Subarachnoid Haemorrhage.Evgen Pharma PLC is a clinical stage drug development company focused on cancer and neurological disease. Its pipeline is based on Sulforadex technology which includes synthetic and stabilized analogues of sulforaphane.

Latest EVG news

Currently there for this company. Visit our news hub for other news .

EVG Regulatory news

Currently there for this company. Visit our news hub for other news .